$EHVVF Ehave (OTC:EHVVF) announced the launch of KetaDASH, an intravenous-based, home delivery platform for patients who have been prescribed Ketamine. The platform will include software, staffing, protocols, and equipment to perform home administrations of ketamine-assisted therapy.
1